Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2/3 1

Status

Completed 103Recruiting 23Active not recruiting 22Terminated 17Unknown 11Withdrawn 8Suspended 2Not yet recruiting 2Enrolling by invitation 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 46Triple Negative Breast Neoplasms 10Prostatic Neoplasms 5Colorectal Neoplasms 5Ovarian Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Uterine Cervical Neoplasms 3Neoplasm Metastasis 3Carcinoma, Renal Cell 3Vulvar Neoplasms 2Stomach Neoplasms 2Sarcoma 2Pancreatic Neoplasms 2Neoplasms 2Melanoma 2Lung Neoplasms 2Endometrial Neoplasms 2Colonic Neoplasms 2Carcinoma, Transitional Cell 2Carcinoma, Intraductal, Noninfiltrating 2Breast Carcinoma In Situ 2Vaginitis 1Uterine Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Osteosarcoma 1Neuroendocrine Tumors 1Multiple Myeloma 1Margins of Excision 1Lymphedema 1Liver Neoplasms 1

Interventions

exemestane 1Tamoxifen 1Magnetic Resonance Spectroscopy 1Letrozole 1Anastrozole 1Absorptiometry, Photon 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Suspended × Breast Carcinoma In Situ × Breast × Clear all
NCT06671912 2026-05-08

LoTam

Alliance for Clinical Trials in Oncology

Phase 3 Suspended
1,156 enrolled
Breast

Breast Carcinoma In Situ

NCT03077841 2026-03-05

Hypofractionated Partial Breast Irradiation in Treating Patients With Early Stage Breast Cancer

M.D. Anderson Cancer Center

Phase 2/3 Suspended
928 enrolled
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡